SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 5

Impact of Chronic Liver Disease on COVID-19 Mortality:The Erciyes University COVID-19 Center Experience

Rinaldo PELLİCANO
Fabio CASTELLANO
Pages
512–512
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Regarding the COVID-19 pandemic, there is a great interest in finding the potential relationship between SARS CoV2 infection, its disease, and different comorbidities in order to predict prognosi

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Regarding the COVID-19 pandemic, there is a great interest in finding the potential relationship between SARS CoV2 infection, its disease, and different comorbidities in order to predict prognosi
📊
Key Findings & Data:Regarding the COVID-19 pandemic, there is a great interest in finding the potential relationship between SARS CoV2 infection, its disease, and different comorbidities in order to predict prognosi
💡
Conclusion & Impact:Regarding the COVID-19 pandemic, there is a great interest in finding the potential relationship between SARS CoV2 infection, its disease, and different comorbidities in order to predict prognosi
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Regarding the COVID-19 pandemic, there is a great interest in finding the potential relationship between SARS CoV2 infection, its disease, and different comorbidities in order to predict prognosi

🔖

Cite This Article

PELLİCANO, R., CASTELLANO, F. (2022). Impact of Chronic Liver Disease on COVID-19 Mortality:The Erciyes University COVID-19 Center Experience. Erciyes Medical Journal, Cilt: 43 - Sayı: 5, 512–512. https://ajindex.com/articles/502242

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Temel Ş, Gündoğan K, Ülger B, Arican H, Bulut K, Sari A, et al. Characteristics and outcomes of the patients infected with SARS-CoV-2 admitted to intensive care Units: Erciyes University COVID-19 center experience. Erciyes Med J 2020; 42(4): 43640
  2. Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Infect 2020; 80(4): 401–6
  3. Singh S, Khan A. Clinical characteristics and outcomes of Coronavirus disease 2019 among patients with pre-existing liver disease in the United States: A multicenter research network study. Gastroenterology 2020; 159(2): 76871.e3
  4. Testino G, Pellicano R. Alcohol consumption in the COVID-19 era. Minerva Gastroenterol Dietol 2020; 66(2): 90–2
  5. Váncsa S, Hegyi PJ, Zádori N, Szakó L, Vörhendi N, Ocskay K, et al. Pre-existing liver diseases and on-admission liver-related laboratory tests in COVID-19: A prognostic accuracy meta-analysis with systematic review. Front Med (Lausanne) 2020; 7: 572115.